Program overview

Break & Dessert

Time: 20:35 - 20:55 CET

Closure

Time: 21:55 - 22:00 CET

Tackling NSCLC with EGFR exon 20 insertion mutation

Time: 21:25 - 21:55 CET

Prof. Dr. Sebahat Ocak (Mont-Godinne, UCL, Namur)

New options for advanced EGFR mutant NSCLC

Time: 20:55 - 21:25 CET

Dr. Antonio Passaro (Eur Institute Oncology, Milan, Italy)

First-line dual immunotherapy for metastatic NSCLC

Time: 20:05 - 20:35 CET

Prof. Dr. Kostas Syrigos (University of Athens, Greece)

Neoadjuvant chemo-immunotherapy: Belgian experience

Time: 19:35 - 20:05 CET

Prof. Dr.  Christophe Dooms (Gasthuisberg & KUL, Leuven)

Opening

Time: 19:30 - 19:35 CET

Prof. Dr. Johan Vansteenkiste, UZ Leuven

Registration & Buffet

Time: 19:00 - 19:30 CET

Closure

Time: 21:55 - 22:00 CET

Break & Dessert

Time: 20:35 - 20:55 CET

Tackling NSCLC with EGFR exon 20 insertion mutation

Time: 21:25 - 21:55 CET

Prof. Dr. Sebahat Ocak (Mont-Godinne, UCL, Namur)

New options for advanced EGFR mutant NSCLC

Time: 20:55 - 21:25 CET

Prof. Dr. Antonio Passaro (Eur Institute Oncology, Milan, Italy)

First-line dual immunotherapy for metastatic NSCLC

Time: 20:05 - 20:35 CET

Prof. Dr. Kostas Syrigos (University of Athens, Athens, Greece)

Neoadjuvant chemo-immunotherapy: Belgian experience

Time: 19:35 - 20:05 CET

Dr. Christophe Dooms (Gasthuisberg & KUL, Leuven)

Opening

Time: 19:32 - 19:35 CET

Prof. Dr. Johan Vansteenkiste (Gasthuisberg & KUL, Leuven)

Moderators

Time: 19:31 - 19:32 CET

Chair: Prof. Dr. Johan Vansteenkiste (Gasthuisberg & KUL, Leuven)
& Co-chair: Dr. Mariana Brandao (Jules Bordet & ULB, Brussels)

Registration & Buffet

Time: 19:00 - 19:30 CET

Closure

Time: 12:45 - 12:50 CET

Prof. Dr. Xavier Geets, Cliniques universitaires Saint-luc

SCLC & mesothelioma

Time: 12:25 - 12:45 CET

Prof. Dr. Sebahat Ocak, CHU UC Louvain Namur

Stage IV ADCs & supportive care

Time: 12:10 - 12:25 CET

Prof. Dr. Annelies Janssens, UZA

Stage IV immunotherapy

Time: 11:55 - 12:10 CET

Prof. Dr. Els Wauters, UZ Leuven

Stage IV targeted therapy

Time: 11:30 - 11:50 CET

Prof. Dr. Christophe Dooms, UZ Leuven

Pathology & biomarkers

Time: 11:15 - 11:30 CET

Dr. Gabriela Beniuga, Institut de Patologie et Génétique Gosselies

2024 in review

Time: 11:13 - 11:14 CET

Coffee Break – Meet sponsors

Time: 10:50 - 11:13 CET

Cases second vote & comments

Time: 10:45 - 10:50 CET

Prof. Dr. Johan Vansteenkiste, University Hospital Ku Leuven

Discussion of the cases

Time: 10:25 - 10:45 CET

Q&A

Time: 10:15 - 10:25 CET

News from RCTs in unresectable disease

Time: 09:55 - 10:15 CET

Dr. Aurelie Debruycker, AZ Groeninge

News from RCTs in resectable disease

Time: 09:35 - 09:55 CET

Prof. Dr. Valerie Lacroix, UCL

The borders of resectabilty

Time: 09:20 - 09:35 CET

Prof. dr. Mariana Brandao, H.U.B

Case presentations & first vote

Time: 09:10 - 09:20 CET

Hot topic 2024: stage II-III NSCLC

Time: 09:08 - 09:09 CET

Introduction

Time: 09:00 - 09:08 CET

Prof. Dr. Johan Vansteenkiste, University Hospital Ku Leuven

Welcome & Registration

Time: 08:30 - 09:00 CET

Coffee Break & e-poster viewing & visiting exhibition

Time: 10:00 - 10:30 CET

Clinical essentials: Surgical factors during cochlea approach and hearing preservation

Time: 09:30 - 10:00 CET

Angel Ramos, Professor in Otorhinolaryngology, University of Las Palmas

Lifelong Sustainable CI Services? How?

Time: 10:30 - 11:30 CET

When and how to optimize language outcomes of children using cochlear implants: learning from the first 10 years of LOCHI children

Time: 10:30 - 11:30 CET

How can we understand how cochlear implants work better, using a range of models

Time: 10:30 - 11:30 CET

How Hearing Loss Impacts Children’s Perception of Emotional Prosody

Time: 10:30 - 11:30 CET

Advanced Bionics

Time: 16:45 - 18:15 CET

Click here to open the programme.

Break

Time: 16:30 - 16:45 CET

MED-EL: “A Whole New Level of Hearing”

Time: 15:00 - 16:30 CET

Break

Time: 14:45 - 15:00 CET

Cochlear™: “Inspired by infinite possibilities”

Time: 13:00 - 13:15 CET

Registratie open

Time: 12:30 - 12:45 CET